Albuquerque, NM: Cannabis flower with elevated levels of specific terpenes are associated with greater perceived symptom relief, according to data published in the Journal of Cannabis Research. A team of researchers affiliated with the University of New Mexico assessed consumers’ perceptions of the efficacy of 633 distinct cannabis flower products. Study participants self-administered cannabis at home and reported symptom changes in real time on …

Modena, Italy: The twice-daily use of THC-dominant plant-derived extracts is associated with symptom mitigation in patients with Alzheimer’s disease (AD), according to observational trial data published in the Italian journal La Clinica Terapeutica. Italian researchers assessed the safety and efficacy of cannabis extracts containing 22 percent THC and 0.5 percent CBD in 30 patients with mild to severe Alzheimer’s disease. Study participants administered the extracts twice …

Suresnes, France: Both current and lifetime cannabis use are associated with lower blood pressure levels, according to data published in the journal Nature: Scientific Reports. A French researcher assessed the relationship between cannabis consumption and blood pressure in a population-based cohort of over 91,000 subjects. The investigator reported: “In adjusted covariates models, lifetime heavy cannabis use was associated with decrease in both SBP [systolic …

Tel Aviv, Israel: The use of cannabis prior to bedtime is associated with improved sleep in patients with treatment-resistant post-traumatic stress (PTS), according to data published in the journal Frontiers in Psychiatry. Israeli researchers evaluated cannabis use in a cohort of 14 subjects with combat-related traumatic stress. Subjects had previously tried various conventional treatments without success. All of the patients were naïve to cannabis prior to …

Saarbrücken, Germany: The use of cannabis-based medicinal products is associated with significant decreases in pain and prescription drug use among patients suffering from chronic pain, according to data published in the German science journal Schmerz. A team of German researchers assessed the efficacy of cannabis-based medicines in a cohort of 187 pain patients. Over 88 percent of patients reported experiencing either significant or moderate …

London, United Kingdom: The use of cannabis products is associated with symptomatic improvements in patients with headache disorders, according to observational trail data published in the journal Expert Review of Neurotherapeutics. British investigators assessed the safety and efficacy of cannabis-derived products in 97 patients diagnosed with migraine and other headache disorders. Study subjects were participants in the UK Medical Cannabis Registry, and each of them possessed a …

Jerusalem, Israel: According to preclinical data published in the journal Cancers, plant-derived extracts containing both CBD and CBC (cannabichromene) are highly effective at killing head and neck cancer cells in culture. Israeli researchers assessed the anti-cancer activity of 24 plant-derived cannabinoids in head and neck cell cultures. They reported that the administration of CBD and CBC at a ratio of two-to-one “maximizes …

Washington, DC: The use of medical cannabis products is associated with substantial long-term decreases in the daily use of prescription opioids among patients suffering from chronic pain, according to data published today in the Journal of the American Medical Association (JAMA) Network Open. Researchers affiliated with the State University of New York at Albany and with the New York State …